Debora A. Jorn
2015
In 2015, Debora A. Jorn earned a total compensation of $5.6M as Executive Vice President, Company Group Chairman at Valeant Pharmaceuticals International, a 146% increase compared to previous year.
Compensation breakdown
| Bonus | $7,968 |
|---|---|
| Salary | $553,077 |
| Stock Awards | $5,014,488 |
| Other | $12,067 |
| Total | $5,587,600 |
Jorn received $5M in stock awards, accounting for 90% of the total pay in 2015.
Jorn also received $8K in bonus, $553.1K in salary and $12.1K in other compensation.
Rankings
In 2015, Debora A. Jorn's compensation ranked 1,376th out of 13,638 executives tracked by ExecPay. In other words, Jorn earned more than 89.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,376 out of 13,638 | 90th |
Division Manufacturing | 479 out of 5,187 | 91st |
Major group Chemicals And Allied Products | 176 out of 1,857 | 91st |
Industry group Drugs | 134 out of 1,531 | 91st |
Industry Pharmaceutical Preparations | 111 out of 1,179 | 91st |
Source: SEC filing on April 29, 2016.
Jorn's colleagues
We found six more compensation records of executives who worked with Debora A. Jorn at Valeant Pharmaceuticals International in 2015.
2015
J Pearson
Valeant Pharmaceuticals International
Chief Executive Officer
2015
Robert Rosiello
Valeant Pharmaceuticals International
Chief Financial Officer
2015
Anne Whitaker
Valeant Pharmaceuticals International
Group Chairman
2015
Brian Stolz
Valeant Pharmaceuticals International
Senior Vice President and General Manager
2015
Ari Kellen
Valeant Pharmaceuticals International
Group Chairman
2015
Howard Schiller
Valeant Pharmaceuticals International